Literature DB >> 19084188

Effect of interleukin-10 overexpression on the properties of healing tendon in a murine patellar tendon model.

Eric T Ricchetti1, Sudheer C Reddy, Heather L Ansorge, Miltiadis H Zgonis, Jonathan P Van Kleunen, Kenneth W Liechty, Louis J Soslowsky, Pedro K Beredjiklian.   

Abstract

PURPOSE: Interleukin-10 (IL-10) is a potent anti-inflammatory cytokine shown to inhibit scar formation in fetal wound healing. The role of IL-10 in adult tendon healing and scar formation, however, remains unknown. The objective of this study is to investigate the effect of IL-10 overexpression on the properties of adult healing tendon using a well-established murine model of tendon injury and a lentiviral-mediated method of IL-10 overexpression.
METHODS: A murine model of patellar tendon injury was used and animals divided into 3 groups. Mice received bilateral patellar tendon injections with a lentiviral vector containing an IL-10 transgene (n = 34) or no transgene (n = 34). Control mice (n = 34) received injections of sterile saline. All animals then were subjected to bilateral, central patellar tendon injuries 2 days after injection and were killed at 5, 10, 21, and 42 days after injury. IL-10 content was analyzed by immunohistochemistry (n = 4/group). Tendon healing was evaluated by histology (n = 4/group) and biomechanical analysis (n = 10/group).
RESULTS: Overexpression of IL-10 in patellar tendon was confirmed after injection of the lentiviral vector. IL-10 immunostaining was increased at day 10 in the IL-10 group relative to that in controls. Histologically, there was no significant difference in angular deviation between groups at day 21, but a trend toward decreased angular deviation in controls relative to that in empty vector group mice was seen at day 42. Biomechanically, the IL-10 group showed significantly increased maximum stress at day 42 relative to that in controls. Percent relaxation showed a trend toward an increase at day 10 and a significant increase at day 42 in the IL-10 group relative to that in controls.
CONCLUSIONS: This study demonstrates successful gene transfer of IL-10 into adult murine patellar tendon using a lentiviral vector. Although the effects of overexpression of IL-10 on adult tendon healing have not yet been fully elucidated, the current study may help to further clarify the mechanisms of tendon injury and repair.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19084188      PMCID: PMC7985602          DOI: 10.1016/j.jhsa.2008.07.020

Source DB:  PubMed          Journal:  J Hand Surg Am        ISSN: 0363-5023            Impact factor:   2.230


  77 in total

1.  Early protected motion after extensor tendon repair.

Authors:  C A Crosby; M A Wehbé
Journal:  J Hand Surg Am       Date:  1999-09       Impact factor: 2.230

2.  Gene transfer to the patellar tendon.

Authors:  T G Gerich; R Kang; F H Fu; P D Robbins; C H Evans
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  1997       Impact factor: 4.342

3.  Gene transfer to the tendon-bone insertion site.

Authors:  Christian Lattermann; Boris A Zelle; Janey D Whalen; Axel W A Baltzer; Paul D Robbins; Christopher Niyibizi; Christopher H Evans; Freddie H Fu
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2004-03-09       Impact factor: 4.342

4.  Optimized large-scale production of high titer lentivirus vector pseudotypes.

Authors:  Miguel Sena-Esteves; Jessica C Tebbets; Sabine Steffens; Timothy Crombleholme; Alan W Flake
Journal:  J Virol Methods       Date:  2004-12-15       Impact factor: 2.014

5.  Results of dynamic splintage following extensor tendon repair.

Authors:  W Y Ip; S P Chow
Journal:  J Hand Surg Br       Date:  1997-04

6.  Interleukin-10 in amniotic fluid at midtrimester: immune activation and suppression in relation to fetal growth.

Authors:  K D Heyborne; J A McGregor; G Henry; S S Witkin; J S Abrams
Journal:  Am J Obstet Gynecol       Date:  1994-07       Impact factor: 8.661

7.  Modulation of JE/MCP-1 expression in dermal wound repair.

Authors:  L A DiPietro; P J Polverini; S M Rahbe; E J Kovacs
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

8.  Intrauterine wound healing in a 20 week human fetus.

Authors:  U Rowlatt
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1979-03-23

9.  Fetal tibial bone healing in utero: the effects of miniplate fixation.

Authors:  R K Slate; J C Posnick; M D Wells; J A Goldstein; F W Keeley; P S Thorner
Journal:  Plast Reconstr Surg       Date:  1993-10       Impact factor: 4.730

10.  Regenerative versus reparative healing in tendon: a study of biomechanical and histological properties in fetal sheep.

Authors:  Pedro K Beredjiklian; Michele Favata; Jeffrey S Cartmell; Colleen L Flanagan; Timothy M Crombleholme; Louis J Soslowsky
Journal:  Ann Biomed Eng       Date:  2003-11       Impact factor: 3.934

View more
  19 in total

1.  In vitro functional response of human tendon cells to different dosages of low-frequency pulsed electromagnetic field.

Authors:  L de Girolamo; M Viganò; E Galliera; D Stanco; S Setti; M G Marazzi; G Thiebat; M M Corsi Romanelli; V Sansone
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-06-24       Impact factor: 4.342

Review 2.  Regenerative Wound Healing: The Role of Interleukin-10.

Authors:  Alice King; Swathi Balaji; Louis D Le; Timothy M Crombleholme; Sundeep G Keswani
Journal:  Adv Wound Care (New Rochelle)       Date:  2014-04-01       Impact factor: 4.730

3.  The low level laser therapy (LLLT) operating in 660 nm reduce gene expression of inflammatory mediators in the experimental model of collagenase-induced rat tendinitis.

Authors:  Romildo Torres-Silva; Rodrigo Alvaro Brandão Lopes-Martins; Jan Magnus Bjordal; Lucio Frigo; Rachid Rahouadj; Gilles Arnold; Ernesto Cesar Pinto Leal-Junior; Jacques Magdalou; Rodney Pallotta; Rodrigo Labat Marcos
Journal:  Lasers Med Sci       Date:  2014-11-08       Impact factor: 3.161

Review 4.  Gene therapy approaches to regenerating the musculoskeletal system.

Authors:  Christopher H Evans; Johnny Huard
Journal:  Nat Rev Rheumatol       Date:  2015-03-17       Impact factor: 20.543

5.  Improvement of tendon repair using muscle grafts transduced with TGF-β1 cDNA.

Authors:  Martin Majewski; Ryan M Porter; Oliver B Betz; Volker M Betz; Harald Clahsen; Rudolf Flückiger; Christopher H Evans
Journal:  Eur Cell Mater       Date:  2012-02-16       Impact factor: 3.942

6.  Photobiomodulation therapy on collagen type I and III, vascular endothelial growth factor, and metalloproteinase in experimentally induced tendinopathy in aged rats.

Authors:  Anna Cristina de Farias Marques; Regiane Albertini; Andrey Jorge Serra; Evela Aparecida Pereira da Silva; Vanessa Lima Cavalcante de Oliveira; Luciana Miatto Silva; Ernesto Cesar Pinto Leal-Junior; Paulo de Tarso Camillo de Carvalho
Journal:  Lasers Med Sci       Date:  2016-09-13       Impact factor: 3.161

7.  Interleukins 4 and 13 modulate gene expression and promote proliferation of primary human tenocytes.

Authors:  Jean-Paul Courneya; Irina G Luzina; Cynthia B Zeller; Jeffrey F Rasmussen; Alexander Bocharov; Lew C Schon; Sergei P Atamas
Journal:  Fibrogenesis Tissue Repair       Date:  2010-06-10

Review 8.  Musculoskeletal regeneration and its implications for the treatment of tendinopathy.

Authors:  Jedd B Sereysky; Evan L Flatow; Nelly Andarawis-Puri
Journal:  Int J Exp Pathol       Date:  2013-06-17       Impact factor: 1.925

9.  Low-level light-emitting diode therapy increases mRNA expressions of IL-10 and type I and III collagens on Achilles tendinitis in rats.

Authors:  Murilo Xavier; Renato Aparecido de Souza; Viviane Araújo Pires; Ana Paula Santos; Flávio Aimbire; José Antônio Silva; Regiane Albertini; Antonio Balbin Villaverde
Journal:  Lasers Med Sci       Date:  2013-02-13       Impact factor: 3.161

10.  Plasma Concentrations of Select Inflammatory Cytokines Predicts Pain Intensity 48 Hours Post-Shoulder Muscle Injury.

Authors:  William C Hedderson; Paul A Borsa; Roger B Fillingim; Stephen A Coombes; Chris J Hass; Steven Z George
Journal:  Clin J Pain       Date:  2020-10       Impact factor: 3.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.